• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 144 filed by Genworth Financial Inc

    5/22/26 12:29:04 PM ET
    $GNW
    Life Insurance
    Finance
    Get the next $GNW alert in real time by email
    Form 144 Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 144

    NOTICE OF PROPOSED SALE OF SECURITIES
    PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

    FORM 144

    144: Filer Information

    Filer CIK
    0001227758
    Filer CCC
    XXXXXXXX
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST

    Submission Contact Information

    Name
    Phone
    E-Mail Address

    144: Issuer Information

    Name of Issuer
    GENWORTH FINANCIAL INC
    SEC File Number
    001-32195
    Address of Issuer
    11011 WEST BROAD STREET
    GLEN ALLEN
    VIRGINIA
    23060
    Phone
    804-281-6000
    Name of Person for Whose Account the Securities are To Be Sold
    RESTREPO ROBERT P JR
    See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

    Relationship to Issuer
    Director

    144: Securities Information

    Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
    Common
    Fidelity Brokerage Services LLC
    900 Salem Street
    Smithfield � RI � 02917
    50000456053.3738300925605/22/2026
    NYSE


    Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

    144: Securities To Be Sold

    Title of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
    Common05/18/2024Restricted Stock VestingIssuerCheckbox not checked2741305/18/2024Compensation
    Common05/23/2025Restricted Stock VestingIssuerCheckbox not checked2258705/23/2025Compensation

    * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



    Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

    144: Securities Sold During The Past 3 Months

    Nothing to ReportCheckbox checked

    144: Remarks and Signature

    Remarks
    Date of Notice
    05/22/2026

    ATTENTION:

    The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
    Signature
    /s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Robert Restrepo

    ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

    Get the next $GNW alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GNW

    DatePrice TargetRatingAnalyst
    6/18/2025$9.00Mkt Perform → Outperform
    Keefe Bruyette
    More analyst ratings

    $GNW
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Pres. & CEO, CareScout Shah Samir B. covered exercise/tax liability with 8,160 shares and converted options into 15,965 shares, increasing direct ownership by 7% to 123,759 units (SEC Form 4) to satisfy tax liability

    4 - GENWORTH FINANCIAL INC (0001276520) (Issuer)

    7/14/26 4:15:26 PM ET
    $GNW
    Life Insurance
    Finance

    President and CEO; Director Mcinerney Thomas J gifted 200,000 shares, decreasing direct ownership by 4% to 5,168,883 units (SEC Form 4)

    4 - GENWORTH FINANCIAL INC (0001276520) (Issuer)

    5/28/26 4:15:28 PM ET
    $GNW
    Life Insurance
    Finance

    President and CEO; Director Mcinerney Thomas J sold $927,000 worth of shares (100,000 units at $9.27), decreasing direct ownership by 2% to 5,368,883 units (SEC Form 4)

    4 - GENWORTH FINANCIAL INC (0001276520) (Issuer)

    5/27/26 4:15:35 PM ET
    $GNW
    Life Insurance
    Finance

    $GNW
    SEC Filings

    View All

    Genworth Financial Inc filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - GENWORTH FINANCIAL INC (0001276520) (Filer)

    7/7/26 4:10:41 PM ET
    $GNW
    Life Insurance
    Finance

    SEC Form 11-K filed by Genworth Financial Inc

    11-K - GENWORTH FINANCIAL INC (0001276520) (Filer)

    6/18/26 5:26:35 PM ET
    $GNW
    Life Insurance
    Finance

    SEC Form 144 filed by Genworth Financial Inc

    144 - GENWORTH FINANCIAL INC (0001276520) (Subject)

    5/22/26 12:29:04 PM ET
    $GNW
    Life Insurance
    Finance

    $GNW
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Genworth Financial Schedules Earnings Conference Call for August 6

    Genworth Financial, Inc. (NYSE:GNW) today announced it will issue its earnings release containing second quarter results after the market closes on August 5, 2026. A conference call will be held on August 6, 2026, at 10:00 a.m. (ET) to discuss the quarter’s results.Genworth’s earnings release, summary presentation and financial supplement will be available through the company's website, http://investor.genworth.com, at the time of their release to the public.Genworth’s conference call will be accessible via telephone and internet. The dial-in number for Genworth’s August 6 conference call is 800-330-6710 or 213-279-1505 (outside the U.S.); conference ID #2307160. To participate in the call b

    7/9/26 4:15:00 PM ET
    $GNW
    $ACT
    Life Insurance
    Finance
    Specialty Insurers

    Genworth Financial President & CEO Thomas J. McInerney to Take Temporary Leave of Absence; Jerome Upton, Genworth CFO, Named Interim President & CEO

    Genworth Financial, Inc. (NYSE:GNW) today announced that Tom McInerney, President & Chief Executive Officer, will be taking a temporary leave of absence from his role to focus on his health. The Board of Directors has named Jerome Upton, currently Genworth’s Chief Financial Officer, as Interim President & Chief Executive Officer, effective immediately. "Our thoughts are with Tom and his family as he recovers, and we look forward to his return," said Melina Higgins, Genworth’s Board Chair. "Genworth is well positioned for continued success with a strong bench of talented leaders. Together with the Board and executive leadership team, I am confident that we will continue during this interim

    7/7/26 4:10:00 PM ET
    $GNW
    $ACT
    Life Insurance
    Finance
    Specialty Insurers

    TheKey and CareScout Surpass 500 Families Supported Through Person-Centered National Home Care Partnership

    Milestone reflects growing demand for trusted, high-quality aging care solutions that can serve families consistently across the countryMINNEAPOLIS, June 17, 2026 /PRNewswire/ -- TheKey and CareScout today announced they have helped more than 500 families begin receiving in-home care through their partnership, reflecting growing demand for trusted, high-quality aging care solutions that can serve families consistently across the country. TheKey is a participating provider in the CareScout Quality Network – the first network of aging care providers where every provider has met rigorous quality standards and committed to person-centered care. The network currently reaches more than 97% of the

    6/17/26 10:19:00 AM ET
    $GNW
    Life Insurance
    Finance

    $GNW
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Genworth Financial upgraded by Keefe Bruyette with a new price target

    Keefe Bruyette upgraded Genworth Financial from Mkt Perform to Outperform and set a new price target of $9.00

    6/18/25 7:44:47 AM ET
    $GNW
    Life Insurance
    Finance

    $GNW
    Leadership Updates

    Live Leadership Updates

    View All

    CareScout, a Genworth Company, Aims to Redefine Quality and Build Trust in Long-Term Care

    CareScout Quality Network brings together providers committed to person-centered care. CareScout today introduced the CareScout Quality Network, a first-of-its-kind group of long-term care providers who meet high standards for quality, person-centered care. "The long-term care industry is ripe for innovation because health and social systems aren't built to support the demand of our rapidly aging population. Older adults and their families are left to navigate a fragmented and confusing experience to find care," said Samir Shah, CEO of CareScout Services. "Quality measures today only meet the lowest common denominator of patient safety, which is important, but provides zero insight into

    2/13/24 8:30:00 AM ET
    $GNW
    Life Insurance
    Finance

    Genworth And Oceanwide Provide Transaction Update; Genworth To Focus on Contingency Plan

    RICHMOND, Va., Jan. 4, 2021 /PRNewswire/ -- Genworth Financial, Inc. (NYSE: GNW) (Genworth, the Company) and China Oceanwide Holdings Group Co., Ltd. (Oceanwide) today provided an update on their pending transaction. Given uncertainty around the completion and timing of the remaining steps required to close the transaction, Genworth and Oceanwide have not extended the current December 31, 2020 "end date" under the merger agreement. Oceanwide has indicated that the factors contributing to the delay since the parties agreed to their most recent extension of the merger agreement on November 30, 2020 were: (a) the finalization of the Hony Capital financing terms; and (b) the COVID-19 pandemi

    1/4/21 7:00:00 AM ET
    $GNW
    Life Insurance
    Finance

    $GNW
    Financials

    Live finance-specific insights

    View All

    Genworth Financial Schedules Earnings Conference Call for August 6

    Genworth Financial, Inc. (NYSE:GNW) today announced it will issue its earnings release containing second quarter results after the market closes on August 5, 2026. A conference call will be held on August 6, 2026, at 10:00 a.m. (ET) to discuss the quarter’s results.Genworth’s earnings release, summary presentation and financial supplement will be available through the company's website, http://investor.genworth.com, at the time of their release to the public.Genworth’s conference call will be accessible via telephone and internet. The dial-in number for Genworth’s August 6 conference call is 800-330-6710 or 213-279-1505 (outside the U.S.); conference ID #2307160. To participate in the call b

    7/9/26 4:15:00 PM ET
    $GNW
    $ACT
    Life Insurance
    Finance
    Specialty Insurers

    Genworth Financial Announces First Quarter 2026 Results

    Strategic Highlights Strong capital returns from Enact, with $99M received in the quarter Repurchased $66M of shares in the quarter; $856M since program inception as of March 31, 2026 CareScout delivered 1,486 matches1 in the quarter with 97% home care coverage of the aged 65-plus census population in the United States Continued progress on the LTC2 MYRAP3 with approximately $34.5B estimated net present value achieved since 2012 from IFAs4 Financial Highlights Net income5 of $47M, or $0.12 per diluted share, and adjusted operating income, excluding Closed Block5,6 of $109M, or $0.28 per diluted share Enact reported adjusted operating income of $140M5 in the quarter; PMI

    5/5/26 4:15:00 PM ET
    $ACT
    $GNW
    Specialty Insurers
    Finance
    Life Insurance

    Genworth Financial Schedules Earnings Conference Call for May 6

    Genworth Financial, Inc. (NYSE:GNW) today announced it will issue its earnings release containing first quarter results after the market closes on May 5, 2026. A conference call will be held on May 6, 2026, at 9:00 a.m. (ET) to discuss the quarter's results. Genworth's earnings release, summary presentation and financial supplement will be available through the company's website, http://investor.genworth.com, at the time of their release to the public. Genworth's conference call will be accessible via telephone and internet. The dial-in number for Genworth's May 6 conference call is 800-330-6710 or 213-279-1505 (outside the U.S.); conference ID #5100219. To participate in the call by we

    4/9/26 4:10:00 PM ET
    $ACT
    $GNW
    Specialty Insurers
    Finance
    Life Insurance

    $GNW
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Genworth Financial Inc

    SC 13G - GENWORTH FINANCIAL INC (0001276520) (Subject)

    10/25/24 3:16:06 PM ET
    $GNW
    Life Insurance
    Finance

    SEC Form SC 13G/A filed by Genworth Financial Inc (Amendment)

    SC 13G/A - GENWORTH FINANCIAL INC (0001276520) (Subject)

    2/13/24 5:06:12 PM ET
    $GNW
    Life Insurance
    Finance

    SEC Form SC 13G filed by Genworth Financial Inc

    SC 13G - GENWORTH FINANCIAL INC (0001276520) (Subject)

    2/9/24 9:59:00 AM ET
    $GNW
    Life Insurance
    Finance